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A B S T R A C T
Main aim of this study is to quantify and analyze the utilization and utilization trends of oral hormonal contracep-
tives in the City of Zagreb, 2008–2010, and to propose potential interventions, if necessary. Data gathered from Zagreb
pharmacies were assessed by Anatomical Therapeutic Chemical Classification of drugs and Daily Defined Dose method-
ology. An alarming decrease in total utilization of hormonal contraceptives by 76% from 2008–2009 was found as the
main result of this study. A major decrease by 95.5% in utilization of G03AB04 subgroup, sequential combined oral con-
traceptives, was noted in the year 2009. The subgroup G03AC0, progesterone-only pill group, showed a stable trend, and
it became the most utilized subgroup in 2010, due to the decrease in utilization of both fixed and sequential combined
oral contraceptives. Utilization of oral contraceptives in Croatia is not regulated adequately, since such dynamics in uti-
lization can occur unnoticed. Measures need to take place in order to improve this situation. Proposed measures include
organized farmacovigilance, prescription based on guidelines, and strict screening for risk factors in women seeking oral
contraception. More research is required in Croatia to understand the pattern of utilization of hormonal contraceptives
and to find the true cause of decrease in utilization of oral contraceptives.
Key words: oral contraceptives, safety, drug, pharmaceutical epidemiology, drug utilizations, ATC/DDD methodol-
ogy, public health
Introduction
Hormonal contraception is an effective, easy to ad-
minister way of preventing unplanned pregnancies, thus
being very eligible for young females who want to achieve
effective family planning. The first contraceptive revolu-
tion began in the 1950s in the USA, with the invention of
hormonal contraceptives and this method was first ap-
proved in the USA in 1960. Nowadays about 100 million
women all over the world are using this birth control
method1. Although this kind of contraception is widely
used, and strongly promoted as an effective and safe
birth control method, it is not withouth flaws. Hormonal
contraceptives may cause several side-effects, including
deep venous thrombosis, acne, mood swings, and can also
increase the risk of breast and cervical cancer, and many
other problems2,3. However, since the data available in
Croatia have not been adequatly evaluated, the true situ-
ation within the Croatian female population is not known.
Therefore, potential issues cannot be dealt with effec-
tively. The utilization of oral contraceptives in Croatia is
still controversial, and comprehension regarding utiliza-
tion trends of oral contraceptives in Croatia is incom-
plete. Even though the G03 group of drugs (sexual hor-
mones) is accountable for two thirds of utilization of the
entire G group (drugs affecting the urogenital system
and sexual hormones), these data are not adequately
assessed4. The capital of Croatia, City of Zagreb was cho-
sen as a representative sample for this study, since it ac-
counts for 18% of the Croatian population and 43% of the
Croatian health resources, and therefore accurately rep-
resents Croatian trends5. Nowadays, it is completely un-
acceptable to have such a poor insight into the utilization
of hormonal contraceptives, therefore, it is absolutely
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necessary to conduct this study, as a first step towards
identifying potential concerns, as well as improving this
important aspect of public health.
Research Objectives
Aims of this study are as follows:
1) To quantify the utilization of oral contraceptives in
the City of Zagreb, the capital of Croatia, between the
years 2008 and 2010, using the Anatomical-Therapeu-
tic-Chemical drug classification (ATC), and the defined
daily doses unit (DDD), or in other words, the ATC/DDD
methodology as a standard method of drug utilization
monitoring
2) To assess the trend in utilization of oral contracep-
tives in the City of Zagreb, during the abovementioned
time span, using ATC/DDD methodology.
Methods
Data on the utilization of hormonal contraceptives
(ATC group G03) in the City of Zagreb were collected be-
tween 2008 and 2010. They were acquired from Zagreb’s
pharmacies that had recorded the data based on individ-
ual prescriptions. All the drugs have been classified ac-
cording to the ATC system. The data acquired have been
used to calculate the DDD by using the indexes of 2008,
2009 and 20106-8. ATC/DDD methodology is generally
recognized as a method for drug utilization quantifica-
tion.
Results
According to the ATC classification, hormonal contra-
ceptives are classified into these three subgroups of cur-
rent interest: G03AA (fixed combinations), G03AB (se-
quential combinations) and G03AC (single-hormone con-
traceptives).
Table 1 represents the total utilization of hormonal
contraceptives in the City of Zagreb expressed in DDDs,
from 2008 – 2010. Subgroup G03AC03 accounts for the
entire utilization of G03AC group of drugs, so this sub-
group was taken into account for this study. There is an
overall decrease in the utilization of all observed sub-
groups. The total number of DDDs decreases between
years 2008 and 2009 by 76%. When comparing years
2009 and 2010, a small increase in utilization expressed
in DDDs by 10.5% is noted. The subgroup G03AB04 ac-
counts for the majority of hormonal contraceptives utili-
zation trough the entire study period, i.e. it makes up for
52% of total utilization of all subgroups, from 2008–2010.
However, the subgroup G03AB04 accounted for 73.7% of
overall G03A group utilization in 2008. A major decrease
by 95.5% in utilization of G03AB04 subgroup expressed
A. Zeli}-Kerep et al.: Utilization of Contraceptives in the City of Zagreb (2008–2010), Coll. Antropol. 38 (2014) 2: 589–593
590
TABLE 1
UTILIZATION OF ORAL CONTRACEPTIVES IN THE CITY OF ZAGREB, 2008–2010, EXPRESSED IN DDDs
ATC code 2008 2009 2010 Total per study period
G03AA 13.353 15.206 12.504 41.063
G03AA13 1.036 810 605 2.451
G03AB 39.122 20.801 14.655 74.578
G03AB04 796.264 36.148 30.016 862.428
G03AC03 231.400 221.000 205.400 657.800
Total G03A 1.081.175 263.180 293.965 1.638.320
Legend: ATC – Anatomical-Therapeutic-Chemical classification, G03AA, G03AA13 – combined oral contraceptives, fixed combina-
tions, G03AB, G03AB04 – combined oral contraceptives, sequential combinations, G03AC03 – progesterone – only contraceptives
TABLE 2
UTILIZATION OF ORAL CONTRACEPTIVES IN THE CITY OF
ZAGREB, 2008–2010, EXPRESSED IN DDDS, TOTAL SUM OF
FIXED AND SEQUENTIAL COMBINED ORAL CONTRACEPTIVES
AND PROGESTERONE-ONLY CONTRACEPTIVES.
ATC code 2008 2009 2010
G03AA 14.389 16.016 13.109
G03AB 835.386 56.949 44.671
G03AC03 231.400 221.000 205.400
Legend: ATC – Anatomical-Therapeutic-Chemical Classification,
G03AA – combined oral contraceptives, fixed combinations,
G03AB – combined oral contraceptives, sequential combina-
tions, G03AC03 – progesterone – only contraceptives
Fig. 1. The overall decrease in the total utilization of oral contra-
ceptives (G03A) in the City of Zagreb, expressed in the number of
Defined Daily Doses (DDDs), 2008–2010.
in DDDs was noted in the year 2009 and in 2010 by an-
other 17%. Subgroup G03AA13 also showed a decrease in
utilization during the observed time span by 42%. Mean-
while, the subgroup G03AC03 has a stable trend, show-
ing a minimal decrease in the utilization expressed in
DDDs, by 12% during the study period. Table 2 shows
the ratio between each subgroup to one another, showing
that the group G03AC03 becomes the most utilized sub-
group in 2009, due to the dramatic decrease in utilization
of other subgroups.
Figures 1 and 2 depict above described data. Figure 1
graphically shows the overall decrease in the total utili-
zation of hormonal contraceptives, while Figure 2 shows
the ratio between the utilization of subgroups during the
study period.
Discussion
As already stated, it was known before that G03 sub-
group (hormonal contraceptives) accounts for two thirds
of entire G group (drugs affecting urogenital system and
sexual hormones) utilization in Croatia. Serious assess-
ment of this data was lacking, making appropriate public
health or otherwise interventions impossible. The prob-
lem lays in the fact that the competent institutions do
not carefully analyze the utilization of hormonal contra-
ceptives. For example, Croatian Institute for Health In-
surance does not have most of the registered oral contra-
ceptives on their drug lists, both basic and additional, so
that institution does not keep track of utilization of the
majority of oral contraceptives in use. Also, Agency for
Medicinal Products and Medical Devices of Croatia keeps
a rough record of utilization, not adequate for finer anal-
yses. It is important to stress that oral contraceptives in
Croatia are not over-the-counter drugs, and only gyneco-
logical specialists prescribe them.
Time span from 2008 –2010 was chosen as a result of
the pursuit to avoid display of vast unnecessary data, but
still to have the most recent data. According to Croatian
Health Service Yearbook 2008, the most common contra-
ceptives prescribed were oral contraceptives (73.1%)9.
From 2008 to 2009 the number of visits to primary
health care’s gynecologists for prescribing hormonal con-
traceptives dropped by 20%10. In 2010 the number of vis-
its to primary health care gynecologists for prescribing
hormonal contraceptives dropped by a mere 0.4%, indi-
cating stabilization11. The results presented in this paper
show a major decrease in the utilization of hormonal con-
traceptives, by 76% from 2008–2009. The number of
abortions dropped by 2%, from 2008–2009, so abortion as
a form of contraception did not cause the decrease in uti-
lization of hormonal contraceptives10. According to pri-
mary health care data, the prescription of all forms of
contraception (oral, intrauterine, the diaphragm and other
local forms) decreased by 30% from 2008–2009, and in
2010 dropped by another 24%. Namely, intrauterine form
of contraception dropped by 23%, the usage of diaphragm
by 61%, and other local forms of birth control by 39%,
from 2008–200912,13. This indicates that this is not the
case of another emerging form of contraception substi-
tuting hormonal contraception. It is clear that an event
occurred in 2008, which could be associated with this
dramatic decrease in utilization of hormonal contracep-
tives. This event could be the deaths by pulmonary em-
bolism of a two young women as side-effects of hormonal
contraception, widely promoted by the Croatian media.
These unfortunate events were caused by a contracep-
tive »Yasmin«, of Bayer d.o.o., a combination of ethinyl-
estradiol and drosiprenone. After these unfortunate
events took place, a safety profile check of the accused
drug was conducted. It was found that all the women
who suffered various major adverse effects, including
abovementioned lethal ones, had other risk factors and
the drug in fact was contraindicated for these women.
The drug was declared to be very safe14. Even though,
there are scientific researches showing contradictive, if
not even opposite results. For example, in 2002 and 2003
some published articles suggest that this combined oral
contraceptive is useful and recommendable, contributing
to women´s overall well-being, and some articles report
transient ischemic attacks and thromboembolic events
associated with Yasmin15,16. The controversy remains the
same in more recently published articles17,18. But, it can-
not be proven that these unfortunate events caused such
dynamics in our data, it can only be guessed. For the time
being, it is the only conclusion that can be made with any
kind of certainty, since the media have a big impact on
public opinion; hormonal contraception is not an excep-
tion. However, it is important to stress that the subgroup
G03AB04 makes up for the majority of hormonal contra-
ceptives utilization, and that the utilization of this sub-
group decreased by 95.5%, from 2008 to 2009. G03AB04
is a code for hormonal contraceptives comprised of nore-
thisterone, a second generation progestin, and oestrogen.
This combination of hormones was the most prescribed
combination of all hormonal contraceptives, till 2009. In
2009 the most prescribed hormonal contraceptives were
the ones in the subgroup G03AC03, the single hormone
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Fig. 2. The ratios between the utilization of subgroups G03AA
(fixed combinations), G03AB (sequential combinations) and
G03AC03 (progesterone-only contraceptives) of oral contracep-
tives expressed in the number of DDDs (Daily Defined Doses) in
the City of Zagreb, during the study period.
oral contraceptives, containing only progestin, possibly
out of fear of oestrogen exacerbating adverse effects.
Since population is still a vitally important policy area
in developing countries, such as Croatia, trends in fertil-
ity are an important focus in public health. The so-called
»second demographic transition«, taking place in devel-
oping and developed countries, Croatia included, charac-
terized by declining age at first intercourse and increas-
ing age at first childbirth, creates an extended interval
during which people are at risk of unintended pregnan-
cy19. According to »World fertility patterns 2009«, a pub-
lication of United Nations´ Department of Economic and
Social Affairs, Population Division, the mean age at child-
bearing in Croatia shifted 1970–2006 from 26 years of
age, to 28 and a half20. Taking that into account, with the
data showing a decline by 76%, in just one year, of hor-
monal contraception utilization creates an alarming im-
age of Croatian public health situation, regarding family
planning and population policy. The result of this study
itself, the decrease in hormonal contraceptives utiliza-
tion by such a great percentage, which was unnoticed by
responsible institutions, is a serious implication for ac-
tion regarding this matter in Croatia.
When it comes to adherence of hormonal contracep-
tion utilization to current trends and the latest findings
regarding safety and efficacy, there are no studies look-
ing into that matter. So far, it is known that the risk of
venous thrombosis in current users of combined oral
contraceptives decreases with duration of use and de-
creasing oestrogen dose. Combined oral contraceptives
containing the same dose of oestrogen with desogestrel,
gestodene, or drospirenone were associated with a signif-
icantly higher risk of venous thrombosis than oral con-
traceptives with levonorgestrel21,22. Progestogen only pills
and hormone releasing intrauterine devices were not as-
sociated with any increased risk of venous thrombosis ac-
cording to a study in 200923. From that point of view, it
can be considered a positive trend, this decline in utiliza-
tion of combined hormonal contraceptives, and a stable
trend in single hormone utilization. Especially since oes-
trogen-containing pills cannot be prescribed to women
who smoke, and it is known that there are numerous fe-
male smokers in Croatia, 21.7%, according to the Health
for All Database24. An extensive meta-analysis in 2011
concludes that in order to exclude the relation between
myocardial infarction and utilization of progestogen-only
contraceptives more research is needed, since current ob-
servational studies suggesting there is no increase in the
risk of myocardial infarction are based on very limited
data25. Also, low-dose combined oral contraceptives are
well tolerated by most women and most mild side-effects
tend to improve over time, when it comes to observing in-
termediate outcomes in combined oral contraceptives26.
The prescription of hormonal contraception in Cro-
atia is clearly out of control, even though concise guide-
lines exist. A better implementation of these guidelines
could improve the state of hormonal contraception in
Croatia. It is important for gynecologists who prescribe
hormonal contraception to know exactly which condi-
tions represent an unacceptable health risk, and even
more important, which do not. Their prescriptions should
be based on concise, already existing guidelines, to elimi-
nate any irrational fear of unwanted events27. All women
seeking hormonal contraception should be vigorously
screened for major and minor risk factors for arterial and
venous diseases28. Other proposed measures include a
better organized farmacovigilance, i.e. all adverse effects
should be regularly noted and analyzed. The most impor-
tant measure that needs to take place is an organized co-
operation between the gynaecologists prescribing these
drugs, responsible institutions and patients themselves.
The data gathered needs to be analyzed continuously and
consequentially.
Certain progress is visible in the developed world re-
garding hormonal contraception, meanwhile in Croatia
there is no awareness about it in the public or in the
health service. Currently, efforts are being made to im-
prove the risk-to-benefit ratio of oral contraception by in-
vestigating the possibility of introducing new, natural
oestrogens and investigating new progestins. Newmolec-
ular methods are being used to discover potential genetic
and proteomic targets for contraception29.
Conclusion
This is the only study investigating this matter using
ATC/DDD methodology, the only methodology qualified
to assess drug utilization in an objective manner. It is of
highest importance to investigate the true reason for
such utilization dynamics, especially to find if this is in
correlation with emergent data suggesting a higher risk
of thromboembolism and other major adverse effects in
relation to new hormonal contraceptives. In order to
achieve the maximum of quality in health services pro-
viding contraception in Croatia results of this study
should be taken into account and proposed measures im-
plemented rapidly.
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ISTRA@IVANJE POTRO[NJE ORALNIH HORMONSKIH KONTRACEPTIVA U GRADU ZAGREBU,
2008–2010 GODINE
S A @ E T A K
Glavni cilj ove studije je kvantificirati i analizirati potro{nju i trendove potro{nje oralnih hormonskih kontraceptiva
u Gradu Zagrebu, 2008–2010 godine, te predlo`iti potencijalne intervencije, ako se poka`e potrebnim. Podaci skupljeni
iz ljekarni Grada Zagreba obra|eni su metodologijom Anatomsko-Terapijsko-Kemijske klasifikacije (ATK) i Definirane
Dnevne Doze (DDD). Alarmantan pad ukupne potro{nje hormonskih kontraceptiva od 76% zabilje`en je od u razdoblju
od 2008. godine do 2009. godine. U 2009. godini do{lo je do pada potro{nje kontraceptiva podgrupe G03AB04, sekven-
cijskih kombiniranih oralnih konraceptiva, za ~ak 95.5%. Podgrupa G03AC0, oralni hormonski kontraceptivi koji sa-
dr`e samo progesteron, pokazuje stabilan trend potro{nje te je postala najprepisivanija podgrupa oralnih hormonskih
kontraceptiva u 2010. godini. To je djelomi~no rezultat pada potro{nje fiksnih i sekvencijskih kombinacija oralnih hor-
monskih kontraceptiva. Potro{nja oralnih hormonskih kontraceptiva u Hrvatskoj nije adekvatno regulirana, {to poka-
zuje ovakva dinamika potro{nje, koja je dosada bila nezapa`ena. Potrebne su intervencije da se ovakva situacija pobolj-
{a. Predlo`ene mjere uklju~uju organiziranu farmakovigilanciju, propisivanje temeljeno na smjernicama i obavezno
detaljno tra`enje faktora rizika u `ena koje `ele oralnu hormonsku kontracepciju. Tako|er, potrebna su dodatna istra-
`ivanja da bi se u potpunosti moglo shvatiti kretanje potro{nje hormonskih kontraceptiva, te da bi se prona{ao pravi
uzrok padu potro{nje oralnih hormonskih kontraceptiva u Hrvatskoj.
A. Zeli}-Kerep et al.: Utilization of Contraceptives in the City of Zagreb (2008–2010), Coll. Antropol. 38 (2014) 2: 589–593
593
